Samsung Bioepis NL B.V.
Track this competitor Create a free account to be notified when it wins a contract.
- Contracts won
- 7
- Shared contracts
- 5 (multi-supplier framework agreements)
- Period
- 1 September 2026 – 1 October 2026
Its main clients
- DAK-Gesundheit · 2 contracts
- Amgros I/S · 2 contracts
- Entidades do Serviço Nacional de Saúde · 1 contract
- OUTRAS INSTITUIÇÕES DE SAÚDE · 1 contract
- Dirección General de Gestión Económica, Contratación e Infraestructuras de la Conselleria de Sanidad · 1 contract
Where and what
Supplies · 7
Its contracts coming to an end
So many opportunities to take over these contracts when they are re-tendered.
| Planned end | Contract | Current holder | Amount |
|---|---|---|---|
| 31 March 2029 re-tender around October 2028 |
Amgros 2027 1.1052.b
Amgros I/S framework agreement |
Biocon Biologics Ireland Limited Orion Pharma A/S Pfizer ApS Samsung Bioepis NL B.V. Accord Healthcare AB Roche Pharmaceuticals A/S Orifarm A/S Abacus Medicine A/S 2care4 ApS 5 bids received |
– |
Contracts won
Source: contract award notices published on TED (Publications Office of the European Union), above the EU thresholds. Contracts published only in Belgium are not included yet.